Patent · US Active

Designed ankyrin repeat proteins binding to platelet-derived growth factor

US9163070B2 · kind B2 · utility

5Cited by

5References

27Claims

0Family size

Assignee

Molecular Partners AG · CH

Inventor

Michael Baumann · Herrenberg, DE

Key dates

Filing date	Jun 27, 2013
Grant date	Oct 20, 2015
Priority date	—
Expiry date	Jun 27, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2318/20
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

New designed ankyrin repeat proteins with binding specificity for PDGF-BB are described, as well as nucleic acids encoding such PDGF binding proteins, pharmaceutical compositions comprising such proteins and the use of such proteins in the treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.